Latest Presentation
DiaMedica Corporate Presentation
Upcoming Events
ASN Kidney Week 2021
12th Annual Craig-Hallum Alpha Select Conference
Piper Sandler 33rd Annual Healthcare Conference
Company Overview
DiaMedica Therapeutics Inc. (Nasdaq: DMAC) is a clinical stage biopharmaceutical company developing recombinant proteins to improve the lives of patients who experience a stroke or recurrent strokes and kidney diseases.
Investor Contact Information
Company
DiaMedica Therapeutics, Inc.
Two Carlson Parkway,
Suite 260
Minneapolis, MN 55447
Investor Relations
LifeSci Advisors, LLC
Timothy McCarthy, CFA
Managing Director, Relationship Manager
T: 212.915.2564
DiaMedica Therapeutics Inc.
Scott Kellen
Chief Financial Officer
T: (763) 496-5192
F: (763) 710-4456
skellen@diamedica.com